Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 16 | 2025 | 1085 | 3.610 |
Why?
|
| Oxidative Stress | 12 | 2018 | 801 | 2.850 |
Why?
|
| Heart Transplantation | 6 | 2025 | 875 | 2.720 |
Why?
|
| Blood Platelets | 12 | 2018 | 323 | 2.710 |
Why?
|
| Air Pollution, Indoor | 9 | 2015 | 34 | 2.650 |
Why?
|
| Heart Failure | 16 | 2025 | 2398 | 2.640 |
Why?
|
| Warm Ischemia | 3 | 2025 | 26 | 2.630 |
Why?
|
| Smoke | 8 | 2018 | 66 | 2.390 |
Why?
|
| Organ Preservation | 3 | 2025 | 52 | 1.960 |
Why?
|
| Hemorrhage | 8 | 2019 | 517 | 1.830 |
Why?
|
| Mitochondria | 4 | 2024 | 751 | 1.630 |
Why?
|
| Antigens, Nuclear | 4 | 2015 | 56 | 1.400 |
Why?
|
| Myocardium | 2 | 2025 | 907 | 1.300 |
Why?
|
| Reactive Oxygen Species | 10 | 2018 | 516 | 1.290 |
Why?
|
| Air Pollutants | 4 | 2013 | 114 | 1.210 |
Why?
|
| Bronchi | 3 | 2015 | 103 | 1.070 |
Why?
|
| Brain Death | 2 | 2025 | 70 | 1.060 |
Why?
|
| Mouth Mucosa | 3 | 2011 | 49 | 0.970 |
Why?
|
| Occupational Exposure | 2 | 2018 | 131 | 0.970 |
Why?
|
| Organ Preservation Solutions | 1 | 2025 | 19 | 0.950 |
Why?
|
| Particulate Matter | 5 | 2015 | 79 | 0.940 |
Why?
|
| Pyroptosis | 1 | 2025 | 30 | 0.930 |
Why?
|
| DNA Damage | 4 | 2013 | 511 | 0.920 |
Why?
|
| Cold Ischemia | 1 | 2025 | 23 | 0.910 |
Why?
|
| Biomass | 5 | 2015 | 23 | 0.910 |
Why?
|
| Apoptosis | 3 | 2017 | 1899 | 0.880 |
Why?
|
| Delirium | 1 | 2025 | 61 | 0.870 |
Why?
|
| Respiratory Mucosa | 2 | 2018 | 96 | 0.860 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2015 | 198 | 0.840 |
Why?
|
| Epithelial Cells | 7 | 2015 | 903 | 0.810 |
Why?
|
| Cell Membrane | 1 | 2025 | 472 | 0.810 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 3 | 2018 | 43 | 0.790 |
Why?
|
| India | 10 | 2018 | 238 | 0.750 |
Why?
|
| Mitochondrial Diseases | 1 | 2024 | 150 | 0.740 |
Why?
|
| Platelet Membrane Glycoproteins | 3 | 2018 | 30 | 0.720 |
Why?
|
| Platelet Activation | 6 | 2017 | 69 | 0.720 |
Why?
|
| Inhalant Abuse | 2 | 2011 | 2 | 0.690 |
Why?
|
| Machine Learning | 1 | 2024 | 348 | 0.680 |
Why?
|
| Brain | 2 | 2025 | 3191 | 0.650 |
Why?
|
| Environmental Exposure | 2 | 2013 | 234 | 0.640 |
Why?
|
| Biofuels | 4 | 2013 | 9 | 0.640 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 509 | 0.590 |
Why?
|
| Curcumin | 1 | 2018 | 43 | 0.580 |
Why?
|
| Stroke | 2 | 2024 | 1082 | 0.580 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2015 | 47 | 0.570 |
Why?
|
| DNA Repair | 2 | 2013 | 567 | 0.570 |
Why?
|
| Smoke Inhalation Injury | 1 | 2018 | 6 | 0.570 |
Why?
|
| Adult | 26 | 2025 | 31557 | 0.570 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2018 | 24 | 0.560 |
Why?
|
| Integrins | 1 | 2017 | 94 | 0.530 |
Why?
|
| Middle Aged | 17 | 2025 | 28979 | 0.530 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 118 | 0.520 |
Why?
|
| Aged | 15 | 2025 | 21456 | 0.520 |
Why?
|
| Lung Transplantation | 1 | 2020 | 336 | 0.510 |
Why?
|
| Tissue Donors | 3 | 2025 | 503 | 0.510 |
Why?
|
| Brain Ischemia | 1 | 2018 | 278 | 0.490 |
Why?
|
| Female | 31 | 2025 | 70691 | 0.480 |
Why?
|
| Blood Platelet Disorders | 1 | 2015 | 14 | 0.460 |
Why?
|
| Humans | 41 | 2025 | 132055 | 0.460 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 234 | 0.450 |
Why?
|
| Cooking | 6 | 2013 | 36 | 0.450 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 846 | 0.450 |
Why?
|
| Neutrophils | 3 | 2012 | 360 | 0.440 |
Why?
|
| Leukocytes | 1 | 2015 | 209 | 0.430 |
Why?
|
| Male | 23 | 2025 | 64944 | 0.420 |
Why?
|
| Sulfur Dioxide | 1 | 2013 | 5 | 0.420 |
Why?
|
| Homeless Youth | 2 | 2011 | 12 | 0.420 |
Why?
|
| Nitrogen Dioxide | 1 | 2013 | 18 | 0.420 |
Why?
|
| Postoperative Complications | 2 | 2025 | 3129 | 0.410 |
Why?
|
| Oxidative Phosphorylation | 2 | 2024 | 124 | 0.410 |
Why?
|
| Stress, Mechanical | 5 | 2015 | 170 | 0.390 |
Why?
|
| Inflammation | 5 | 2023 | 1522 | 0.370 |
Why?
|
| Precancerous Conditions | 1 | 2015 | 278 | 0.370 |
Why?
|
| Soil | 2 | 2009 | 71 | 0.360 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2011 | 6 | 0.350 |
Why?
|
| Oncogene Protein v-akt | 1 | 2010 | 33 | 0.340 |
Why?
|
| Behavior, Addictive | 1 | 2011 | 59 | 0.330 |
Why?
|
| Kidney | 4 | 2025 | 1338 | 0.330 |
Why?
|
| Adhesives | 1 | 2010 | 10 | 0.330 |
Why?
|
| Micronucleus Tests | 1 | 2010 | 3 | 0.330 |
Why?
|
| Mouth | 1 | 2011 | 68 | 0.330 |
Why?
|
| Fertilizers | 1 | 2009 | 4 | 0.320 |
Why?
|
| Brassica | 1 | 2009 | 16 | 0.310 |
Why?
|
| Thrombosis | 4 | 2019 | 528 | 0.310 |
Why?
|
| Superoxide Dismutase | 4 | 2015 | 176 | 0.310 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 2438 | 0.310 |
Why?
|
| Nucleolus Organizer Region | 1 | 2009 | 3 | 0.300 |
Why?
|
| Lymphocytes | 1 | 2010 | 364 | 0.300 |
Why?
|
| Platelet Function Tests | 4 | 2015 | 41 | 0.280 |
Why?
|
| Heart | 2 | 2023 | 689 | 0.270 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 1540 | 0.270 |
Why?
|
| Triticum | 1 | 2007 | 34 | 0.260 |
Why?
|
| Procaine | 1 | 2025 | 12 | 0.240 |
Why?
|
| Lipoproteins, LDL | 2 | 2017 | 133 | 0.240 |
Why?
|
| Disaccharides | 1 | 2025 | 21 | 0.240 |
Why?
|
| Mannitol | 1 | 2025 | 43 | 0.240 |
Why?
|
| Electrolytes | 1 | 2025 | 58 | 0.240 |
Why?
|
| Histidine | 1 | 2025 | 77 | 0.240 |
Why?
|
| Glutamates | 1 | 2025 | 69 | 0.230 |
Why?
|
| Coenzyme A Ligases | 1 | 2025 | 12 | 0.230 |
Why?
|
| Endostatins | 1 | 2025 | 8 | 0.230 |
Why?
|
| Preoperative Period | 1 | 2025 | 92 | 0.230 |
Why?
|
| Lipid Peroxidation | 1 | 2025 | 93 | 0.230 |
Why?
|
| Time Factors | 2 | 2025 | 6442 | 0.230 |
Why?
|
| Cystatin C | 1 | 2025 | 74 | 0.220 |
Why?
|
| Atrophy | 1 | 2025 | 251 | 0.220 |
Why?
|
| Glutathione | 1 | 2025 | 200 | 0.210 |
Why?
|
| Organ Size | 1 | 2025 | 447 | 0.210 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 2087 | 0.210 |
Why?
|
| Oxidoreductases | 1 | 2024 | 101 | 0.200 |
Why?
|
| NADPH Oxidases | 1 | 2024 | 111 | 0.200 |
Why?
|
| Death | 1 | 2024 | 79 | 0.200 |
Why?
|
| Flow Cytometry | 3 | 2015 | 802 | 0.200 |
Why?
|
| Edema | 1 | 2023 | 144 | 0.190 |
Why?
|
| Iron | 1 | 2025 | 302 | 0.190 |
Why?
|
| Neuroimaging | 1 | 2025 | 375 | 0.180 |
Why?
|
| Fibrosis | 1 | 2023 | 421 | 0.180 |
Why?
|
| Premenopause | 2 | 2012 | 40 | 0.180 |
Why?
|
| Glucose | 1 | 2025 | 871 | 0.170 |
Why?
|
| Blood-Brain Barrier | 2 | 2018 | 156 | 0.170 |
Why?
|
| Cheek | 2 | 2011 | 25 | 0.170 |
Why?
|
| Biomarkers | 4 | 2025 | 3403 | 0.170 |
Why?
|
| von Willebrand Factor | 3 | 2017 | 192 | 0.160 |
Why?
|
| Perfusion | 1 | 2020 | 208 | 0.160 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2017 | 65 | 0.150 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2018 | 36 | 0.150 |
Why?
|
| Plant Shoots | 2 | 2009 | 7 | 0.150 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2018 | 5 | 0.140 |
Why?
|
| Plant Roots | 2 | 2009 | 31 | 0.140 |
Why?
|
| Plant Leaves | 2 | 2009 | 55 | 0.140 |
Why?
|
| Shear Strength | 1 | 2017 | 17 | 0.140 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 110 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 2010 | 591 | 0.140 |
Why?
|
| Acute Kidney Injury | 1 | 2025 | 670 | 0.140 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 126 | 0.130 |
Why?
|
| Hemostatics | 1 | 2017 | 60 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 85 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 289 | 0.130 |
Why?
|
| Blood Coagulation | 2 | 2015 | 129 | 0.130 |
Why?
|
| Diabetes, Gestational | 1 | 2018 | 114 | 0.130 |
Why?
|
| Ethanol | 1 | 2018 | 162 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 2163 | 0.130 |
Why?
|
| Young Adult | 6 | 2018 | 9938 | 0.130 |
Why?
|
| Platelet Aggregation | 4 | 2017 | 106 | 0.120 |
Why?
|
| Malondialdehyde | 1 | 2015 | 52 | 0.120 |
Why?
|
| Risk | 2 | 2015 | 761 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 826 | 0.110 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 436 | 0.110 |
Why?
|
| Statistics as Topic | 1 | 2015 | 254 | 0.110 |
Why?
|
| Particle Size | 2 | 2011 | 149 | 0.110 |
Why?
|
| Inhalation Exposure | 2 | 2011 | 35 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2024 | 17367 | 0.110 |
Why?
|
| Metaplasia | 1 | 2015 | 217 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 327 | 0.100 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 153 | 0.100 |
Why?
|
| Sputum | 2 | 2011 | 116 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2018 | 3414 | 0.100 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 314 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2015 | 260 | 0.100 |
Why?
|
| Environmental Monitoring | 1 | 2013 | 90 | 0.100 |
Why?
|
| Lung | 1 | 2020 | 1556 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2015 | 212 | 0.100 |
Why?
|
| Logistic Models | 2 | 2015 | 1836 | 0.100 |
Why?
|
| Neutrophil Activation | 1 | 2012 | 12 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 4753 | 0.090 |
Why?
|
| Comet Assay | 1 | 2011 | 7 | 0.090 |
Why?
|
| Risk Factors | 4 | 2024 | 10936 | 0.090 |
Why?
|
| Natural Gas | 1 | 2011 | 5 | 0.090 |
Why?
|
| Hazardous Substances | 1 | 2011 | 18 | 0.090 |
Why?
|
| Rural Health | 1 | 2010 | 44 | 0.080 |
Why?
|
| Macrophages, Alveolar | 1 | 2010 | 47 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 375 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1596 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2010 | 269 | 0.080 |
Why?
|
| Rural Population | 1 | 2011 | 242 | 0.080 |
Why?
|
| Seeds | 1 | 2009 | 39 | 0.080 |
Why?
|
| Energy-Generating Resources | 1 | 2009 | 1 | 0.080 |
Why?
|
| Silver Staining | 1 | 2009 | 5 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 826 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 502 | 0.070 |
Why?
|
| Temperature | 1 | 2009 | 302 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 448 | 0.070 |
Why?
|
| Chlorophyll | 1 | 2007 | 5 | 0.070 |
Why?
|
| Soil Microbiology | 1 | 2007 | 14 | 0.070 |
Why?
|
| Colony Count, Microbial | 1 | 2007 | 87 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2010 | 1611 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 3086 | 0.060 |
Why?
|
| Carotenoids | 1 | 2007 | 79 | 0.060 |
Why?
|
| P-Selectin | 2 | 2015 | 68 | 0.060 |
Why?
|
| Adolescent | 2 | 2011 | 20530 | 0.050 |
Why?
|
| Animals | 2 | 2018 | 34823 | 0.040 |
Why?
|
| Child | 3 | 2011 | 25758 | 0.040 |
Why?
|
| Acanthosis Nigricans | 1 | 2018 | 11 | 0.040 |
Why?
|
| Normal Distribution | 1 | 2018 | 20 | 0.040 |
Why?
|
| Hyperhomocysteinemia | 1 | 2018 | 37 | 0.040 |
Why?
|
| Capillary Permeability | 1 | 2018 | 74 | 0.030 |
Why?
|
| Homocysteine | 1 | 2018 | 120 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 258 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 152 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2017 | 157 | 0.030 |
Why?
|
| Exercise Test | 1 | 2018 | 256 | 0.030 |
Why?
|
| Propensity Score | 1 | 2017 | 255 | 0.030 |
Why?
|
| Collagen | 1 | 2017 | 303 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2018 | 183 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 469 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2018 | 1007 | 0.030 |
Why?
|
| Registries | 1 | 2022 | 1591 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2018 | 506 | 0.030 |
Why?
|
| Cell-Derived Microparticles | 1 | 2015 | 29 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 476 | 0.030 |
Why?
|
| Heart, Artificial | 1 | 2015 | 69 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 6556 | 0.030 |
Why?
|
| Monocytes | 1 | 2015 | 342 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2013 | 229 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 753 | 0.020 |
Why?
|
| Receptors, Complement 3b | 1 | 2012 | 10 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2018 | 1402 | 0.020 |
Why?
|
| CD18 Antigens | 1 | 2012 | 44 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2012 | 39 | 0.020 |
Why?
|
| Peroxidase | 1 | 2012 | 64 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2012 | 62 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 92 | 0.020 |
Why?
|
| Prevalence | 1 | 2018 | 2662 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2012 | 249 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 2015 | 331 | 0.020 |
Why?
|
| Interleukins | 1 | 2012 | 129 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2015 | 515 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 618 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 3753 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 666 | 0.020 |
Why?
|
| Antioxidants | 1 | 2011 | 333 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2012 | 470 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 899 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3358 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 13015 | 0.020 |
Why?
|
| Long QT Syndrome | 1 | 1986 | 85 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 7536 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 3370 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1986 | 479 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 7125 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 3984 | 0.010 |
Why?
|
| Mice | 1 | 2018 | 18488 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 4716 | 0.010 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 1986 | 10 | 0.000 |
Why?
|